Package 71610-813-26

{"route": ["ORAL"], "spl_id": "1547a408-12a9-fadd-e063-6394a90a4ce0", "openfda": {"nui": ["N0000175598", "N0000175086"], "unii": ["N7Z035406B"], "rxcui": ["242461"], "spl_set_id": ["15478d90-312f-014e-e063-6294a90ae838"], "pharm_class_epc": ["Phosphodiesterase 3 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 3 Inhibitors [MoA]"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "1200 TABLET in 1 BOTTLE (71610-813-26)", "package_ndc": "71610-813-26", "marketing_start_date": "20240403"}], "brand_name": "cilostazol", "product_id": "71610-813_1547a408-12a9-fadd-e063-6394a90a4ce0", "dosage_form": "TABLET", "pharm_class": ["Phosphodiesterase 3 Inhibitor [EPC]", "Phosphodiesterase 3 Inhibitors [MoA]"], "product_ndc": "71610-813", "generic_name": "cilostazol", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "cilostazol", "active_ingredients": [{"name": "CILOSTAZOL", "strength": "100 mg/1"}], "application_number": "ANDA077030", "marketing_category": "ANDA", "marketing_start_date": "20220412", "listing_expiration_date": "20261231"}